Chemed Corporation (NYSE: CHE) reported Q4 EPS of $6.83, $0.05 better than the analyst estimate of $6.78. Revenue for the quarter came in at $640 million versus the consensus estimate of $636.1 million.

For earnings history and earnings-related data on Chemed Corporation (CHE) click here.